SWA
CTSO icon

SFMG Wealth Advisors’s Cytosorbents Corp CTSO Stock Holding History

SFMG Wealth Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.48K Buy
+20,000
New +$10.6K ﹤0.01% 343

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

SFMG Wealth Advisors's CTSO Position: Q2 2026 in Review

SFMG Wealth Advisors opened a new position in Cytosorbents Corp (CTSO) in Q2 2026: 20,000 shares worth $7.48K. The stake represents ﹤0.01% of the portfolio and ranks #343 among its holdings.

51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • SFMG Wealth Advisors held 20,000 shares of Cytosorbents Corp worth $7.48K as of Q2 2026.
  • Cytosorbents Corp was a new SFMG Wealth Advisors position in Q2 2026.
  • Cytosorbents Corp made up ﹤0.01% of SFMG Wealth Advisors's portfolio in Q2 2026, its #343 holding.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on SFMG Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.